Skip to main content

Agilent Buys Molecular Imaging in Bid to Expand Nanotech Imaging Business

NEW YORK, Nov. 29 (GenomeWeb News) - Agilent Technologies has acquired privately held Molecular Imaging for an undisclosed amount, the company announced today.

 

Tempe, Ariz.-based Molecular Imaging makes PicoPlus, a line of atomic force microscopes, which comprise a significant portion of the $1 billion market for nanotechnology imaging and measurement tools.

 

Agilent's chief business areas are electronic measurements and analytical measurements. With this acquisition, Agilent expands its nanotechnology imaging portfolio.

 

Since Molecular Imaging has an ongoing relationship with Arizona State University extending back to 1993, Agilent will not move operations from Tempe, the company said. Molecular Imaging's employees have joined Agilent, the company said.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.